E1	Observation:T1 Name:T2 Numeric-Filter:E2 Numeric-Filter:E3
E2	Eq-Comparison:T3 Value:T4 Unit:T5 Operator:T6
E3	Eq-Comparison:T7 Operator:T8 Value:T9 Unit:T10
E4	Observation:T11 Name:T12 Numeric-Filter:E5
E5	Eq-Comparison:T13 Operator:T14 Value:T15 Unit:T16 Per:T17
E6	Observation:T18 Name:T19
E7	Eq-Comparison:T20 Operator:T21 Value:T22 Unit:T23 Per:T24
E8	Observation:T25 Name:T26 Numeric-Filter:E9
E9	Eq-Comparison:T27 Operator:T28 Value:T29 Unit:T30
E10	Observation:T31 Name:T32 Numeric-Filter:E11
E11	Eq-Comparison:T33 Operator:T34 Value:T35 Unit:T36
E13	Assertion:T38 Asserted:E15
E14	Modifier:T39 Modifies:T41
E15	Condition:T40 Name:T41
E16	Condition:T42 Name:T43
E17	Condition:T44 Name:T45
E19	Modifier:T47 Modifies:T43
E20	Modifier:T48 Modifies:T43
E23	Eq-Comparison:T51 Temporal-Period:T52
E24	Condition:T53 Name:T54 Severity:T57 Temporality:E23
E25	Eq-Comparison:T55 Value:T56 Operator:T58 Value2:T57
E26	Condition:T59 Name:T60
E27	Condition:T61 Name:T62
E28	Condition:T63 Name:T64
E29	Condition:T65 Name:T66 Stability:T67 Temporality:E31
E31	Eq-Comparison:T69 Temporal-Period:T70 Value:T71 Temporal-Unit:T72
E32	Condition:T73 Name:T74 Severity:T75
E33	Observation:T76 Name:T77 Numeric-Filter:E34
E34	Eq-Comparison:T78 Value:T79 Value2:T80 Unit:T81
E35	Condition:T82 Name:T83
E36	Drug:T84 Name:T85
E37	Drug:T87 Name:T86
E39	Eq-Comparison:T89 Temporal-Period:T90
E40	Condition:T91 Name:T92 Temporality:E39
E41	Procedure:T93 
E43	Drug:T95 Name:T96
E44	Drug:T97 Name:T98
E46	Observation:T100 Name:T101 Numeric-Filter:E47
E47	Eq-Comparison:T102 Operator:T103 Value:T104 Unit:T105
E48	Observation:T106 Name:T107 Numeric-Filter:E49
E49	Eq-Comparison:T108 Operator:T109 Value:T110 Unit:T111 Per:T112
E50	Observation:T113 Name:T114
E51	Observation:T115 Name:T116
E53	Eq-Comparison:T118 Operator:T119 Value:T120 Unit:T121
E54	Observation:T122 Name:T123 Numeric-Filter:E55
E55	Eq-Comparison:T124 Operator:T125 Value:T126 Unit:T127 Per:T128
E56	Study:T129 Stability:T130
E57	Assertion:T131 Asserted:T130
E58	Condition:T132 
T1	Observation 36 41	msSBP
T2	Observation-Name 36 41	msSBP
T3	Eq-Comparison 25 35	145 mmHg ≤
T4	Eq-Value 25 28	145
T5	Eq-Unit 29 33	mmHg
T6	Eq-Operator 34 35	≤
T7	Eq-Comparison 42 52	≤ 190 mmHg
T8	Eq-Operator 42 43	≤
T9	Eq-Value 44 47	190
T10	Eq-Unit 48 52	mmHg
T11	Observation 58 71	Triglycerides
T12	Observation-Name 58 71	Triglycerides
T13	Eq-Comparison 72 83	< 500 mg/dL
T14	Eq-Operator 72 73	<
T15	Eq-Value 74 77	500
T16	Eq-Unit 78 80	mg
T17	Eq-Unit 81 83	dL
T18	Observation 89 94	LDL-C
T19	Observation-Name 89 94	LDL-C
T20	Eq-Comparison 95 106	≤ 250 mg/dL
T21	Eq-Operator 95 96	≤
T22	Eq-Value 97 100	250
T23	Eq-Unit 101 103	mg
T24	Eq-Unit 104 106	dL
T25	Observation 132 136	sSBP
T26	Observation-Name 132 136	sSBP
T27	Eq-Comparison 137 145	≥ 20mmHg
T28	Eq-Operator 137 138	≥
T29	Eq-Value 139 141	20
T30	Eq-Unit 141 145	mmHg
T31	Observation 150 154	sDBP
T32	Observation-Name 150 154	sDBP
T33	Eq-Comparison 155 163	≥ 10mmHg
T34	Eq-Operator 155 156	≥
T35	Eq-Value 157 159	10
T36	Eq-Unit 159 163	mmHg
T38	Assertion 169 180	symptomatic
T39	Modifier 181 192	orthostatic
T40	Condition 193 204	hypotension
T41	Condition-Name 193 204	hypotension
T42	Condition 230 242	hypertension
T43	Condition-Name 230 242	hypertension
T44	Condition 247 259	dyslipidemia
T45	Condition-Name 247 259	dyslipidemia
T47	Modifier 219 229	iatrogenic
T48	Modifier 209 218	secondary
T51	Eq-Comparison 265 272	history
T52	Eq-Temporal-Period 265 272	history
T53	Condition 295 312	cerebral ischemia
T54	Condition-Name 295 312	cerebral ischemia
T55	Eq-Comparison 276 294	moderate to severe
T56	Severity 276 284	moderate
T57	Severity 288 294	severe
T58	Eq-Operator 285 287	to
T59	Condition 314 333	cerebral hemorrhage
T60	Condition-Name 314 333	cerebral hemorrhage
T61	Condition 335 360	transient ischemic attack
T62	Condition-Name 335 360	transient ischemic attack
T63	Condition 362 383	myocardial infarction
T64	Condition-Name 362 383	myocardial infarction
T65	Condition 397 403	angina
T66	Condition-Name 397 403	angina
T67	Stability 388 396	unstable
T69	Eq-Comparison 411 424	past 6 months
T70	Eq-Temporal-Period 411 415	past
T71	Eq-Value 416 417	6
T72	Eq-Temporal-Unit 418 424	months
T73	Condition 433 446	heart failure
T74	Condition-Name 433 446	heart failure
T75	Severity 426 432	severe
T76	Observation 448 474	New York Heart Association
T77	Observation-Name 448 474	New York Heart Association
T78	Eq-Comparison 486 502	class III and IV
T79	Eq-Value 492 495	III
T80	Eq-Value 500 502	IV
T81	Eq-Unit 486 491	class
T82	Condition 509 525	hypersensitivity
T83	Condition-Name 509 525	hypersensitivity
T84	Drug 529 540	telmisartan
T85	Drug-Name 529 540	telmisartan
T86	Drug-Name 544 556	rosuvastatin
T87	Drug 544 556	rosuvastatin
T89	Eq-Comparison 562 569	history
T90	Eq-Temporal-Period 562 569	history
T91	Condition 573 583	angioedema
T92	Condition-Name 573 583	angioedema
T93	Procedure 590 599	treatment
T95	Drug 605 645	angiotensin-converting enzyme inhibitors
T96	Drug-Name 605 645	angiotensin-converting enzyme inhibitors
T97	Drug 649 653	ARBs
T98	Drug-Name 649 653	ARBs
T100	Observation 655 679	creatinine phosphokinase
T101	Observation-Name 655 679	creatinine phosphokinase
T102	Eq-Comparison 687 721	≥3 times the upper limit of normal
T103	Eq-Operator 687 688	≥
T104	Eq-Value 688 689	3
T105	Eq-Unit 700 721	upper limit of normal
T106	Observation 727 763	estimated glomerular filtration rate
T107	Observation-Name 727 763	estimated glomerular filtration rate
T108	Eq-Comparison 764 774	≤30 mL/min
T109	Eq-Operator 764 765	≤
T110	Eq-Value 765 767	30
T111	Eq-Unit 768 770	mL
T112	Eq-Temporal-Unit 771 774	min
T113	Observation 776 802	aspartate aminotransferase
T114	Observation-Name 776 802	aspartate aminotransferase
T115	Observation 807 831	alanine aminotransferase
T116	Observation-Name 807 831	alanine aminotransferase
T118	Eq-Comparison 839 873	≥3 times the upper limit of normal
T119	Eq-Operator 839 840	≥
T120	Eq-Value 840 841	3
T121	Eq-Unit 852 873	upper limit of normal
T122	Observation 879 888	potassium
T123	Observation-Name 879 888	potassium
T124	Eq-Comparison 896 907	>5.5 mmol/L
T125	Eq-Operator 896 897	>
T126	Eq-Value 897 900	5.5
T127	Eq-Unit 901 905	mmol
T128	Eq-Unit 906 907	L
T129	Study 962 967	study
T130	Stability 936 942	affect
T131	Assertion 930 935	could
T132	Condition 916 924	diseases
A1	Observation-Type-Value E1 vital
A2	Eq-Operator-Value T6 LTEQ
A3	Eq-Operator-Value T8 LTEQ
A4	Observation-Type-Value E4 lab
A5	Eq-Operator-Value T14 LT
A6	Observation-Type-Value E6 lab
A7	Eq-Operator-Value T21 LTEQ
A8	Observation-Type-Value E8 vital
A9	Eq-Operator-Value T28 GTEQ
A10	Observation-Type-Value E10 vital
A11	Eq-Operator-Value T34 GTEQ
A12	Assertion-Type-Value E13 possible
A13	Eq-Temporal-Period-Value T52 past
A14	Severity-Value T56 moderate
A15	Severity-Value T57 severe
A16	Eq-Operator-Value T58 BETWEEN
A17	Stability-Value T67 change
A18	Eq-Temporal-Period-Value T70 past
A19	Eq-Temporal-Unit-Value T72 month
A20	Severity-Value T75 severe
A21	Eq-Temporal-Period-Value T90 past
A23	Observation-Type-Value E46 lab
A24	Eq-Operator-Value T103 GTEQ
A25	Eq-Unit-Value T105 ref-range-normal
A26	Observation-Type-Value E48 lab
A27	Eq-Operator-Value T109 LTEQ
A28	Eq-Temporal-Unit-Value T112 minute
A29	Observation-Type-Value E50 lab
A30	Observation-Type-Value E51 lab
A31	Eq-Operator-Value T119 GTEQ
A32	Eq-Unit-Value T121 ref-range-normal
A33	Observation-Type-Value E54 lab
A34	Eq-Operator-Value T125 GT
A35	Stability-Value T130 change
A36	Assertion-Type-Value E57 hypothetical
A37	Observation-Type-Value E33 clinical-score
R1	Equivalent-To Arg1:E33 Arg2:E32
R2	Caused-By Arg1:E35 Arg2:E36
R3	Caused-By Arg1:E35 Arg2:E37
R4	Using Arg1:E41 Arg2:E43
R5	Caused-By Arg1:T130 Arg2:E58
R6	And Arg1:E8 Arg2:E10
R7	Or Arg1:E16 Arg2:E17
R8	Or Arg1:E20 Arg2:E19
R9	Or Arg1:E15 Arg2:E16
R10	Or Arg1:E28 Arg2:E29
R11	Or Arg1:E36 Arg2:E37
R12	After Arg1:E40 Arg2:E41
R13	Or Arg1:E43 Arg2:E44
R14	Or Arg1:E50 Arg2:E51
R15	Or Arg1:E54 Arg2:E58
R16	Or Arg1:E24 Arg2:E26
R17	Or Arg1:E26 Arg2:E27
R18	Or Arg1:E27 Arg2:E28
